Keywords: AAV; adeno-associated virus; BBB; blood-brain barrier; BBBD; blood-brain barrier disruption; BCNU; bis-chloroethylnitrosourea or carmustine; BNCT; boron neutron capture therapy; BPN; brain-penetrating nanoparticle; CNS; central nervous system; DOX; do